Cardiac Ablation Has A 50% Problem, Here's The Fix with Andreu Climent

Jordan is joined by Andreu Climent, CEO of Corify Care, a cardiac mapping company using non-invasive, whole-heart technology to guide EP procedures in real time. Andreu brings a telecoms engineering background to a problem most cardiologists have accepted as unsolvable: that half of all AF ablations fail, because clinicians are operating without seeing the full picture.

They cover how Corify's cardiac global mapping system works, how it has more than doubled ablation efficacy in pilot studies, and what a partnership with Mayo Clinic means for the future of predictive cardiac care. Andreu also gets into the realities of taking a seven-year research project to commercial launch and what it really takes to change clinical behaviour.

Key Topics

• How Corify's whole-heart mapping system works

• The limitations of current EP ablation standards of care

• Doubling AF ablation efficacy with guided, personalised treatment

• The Mayo Clinic partnership and the AI for AF project

• Scaling from academic research to commercial launch and US market entry

Related Insights

• Why coming from outside cardiology helped Andreu challenge assumptions baked into the standard of care

• The case for personalised, data-guided ablation over empirical, one-size-fits-all approaches

• How predictive mapping could identify arrhythmia risk years before symptoms appear

• What it takes to shift VC interest as clinical and regulatory risk drops

Core Challenges

• Current AF ablation is largely empirical, with success rates of 50-60%. Half of patients return after a failed procedure, and clinicians have no reliable way to know in advance whether a treatment will work for a given patient.

• Changing established clinical behaviour is slow, even when the data clearly supports a better approach. Getting buy-in requires more than proof — it requires presence in the cath lab and time.

🎧 Tune in now to find out how Andreu Climent and Corify Care are replacing guesswork in the EP lab with real-time, whole-heart mapping.